GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Apollon Wealth Management LLC

Apollon Wealth Management LLC raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 46.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,111 shares of the company’s stock after purchasing an additional 4,160 shares during the quarter. Apollon Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $1,025,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. LGT Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $31,000. Finally, Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $87.03 on Wednesday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.55. The company has a market capitalization of $39.76 billion, a price-to-earnings ratio of 23.91, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The firm’s fifty day moving average price is $83.52 and its 200 day moving average price is $85.38.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.